Chapter/Section Purchase

1 Study Coverage
1.1 Recombinant Human Granulocyte Colony-Stimulating Product Introduction
1.2 Global Recombinant Human Granulocyte Colony-Stimulating Outlook 2017 VS 2022 VS 2028
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in US$ Million for the Year 2017-2028
1.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume for the Year 2017-2028
1.3 United States Recombinant Human Granulocyte Colony-Stimulating Outlook 2017 VS 2022 VS 2028
1.3.1 United States Recombinant Human Granulocyte Colony-Stimulating Sales in US$ Million for the Year 2017-2028
1.3.2 United States Recombinant Human Granulocyte Colony-Stimulating Sales in Volume for the Year 2017-2028
1.4 Recombinant Human Granulocyte Colony-Stimulating Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Recombinant Human Granulocyte Colony-Stimulating in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Recombinant Human Granulocyte Colony-Stimulating Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Recombinant Human Granulocyte Colony-Stimulating Market Dynamics
1.5.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends
1.5.2 Recombinant Human Granulocyte Colony-Stimulating Market Drivers
1.5.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges
1.5.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Recombinant Human Granulocyte Colony-Stimulating Market Segment by Type
2.1.1 Lenograstim (Granocyte)
2.1.2 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
2.1.3 Others
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
2.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
2.3.1 United States Recombinant Human Granulocyte Colony-Stimulating Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Recombinant Human Granulocyte Colony-Stimulating Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Recombinant Human Granulocyte Colony-Stimulating Market Segment by Application
3.1.1 Chemotherapy Induced Neutropenia
3.1.2 Before Blood Donation
3.1.3 Stem Cell Transplants
3.1.4 Others
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
3.3.1 United States Recombinant Human Granulocyte Colony-Stimulating Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Recombinant Human Granulocyte Colony-Stimulating Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Recombinant Human Granulocyte Colony-Stimulating Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Human Granulocyte Colony-Stimulating Competitor Landscape by Company
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Company
4.1.1 Top Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Ranked by Revenue (2021)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturer (2017-2022)
4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturer (2017-2022)
4.1.4 Global Recombinant Human Granulocyte Colony-Stimulating Price by Manufacturer (2017-2022)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Concentration Ratio (CR)
4.2.1 Recombinant Human Granulocyte Colony-Stimulating Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Human Granulocyte Colony-Stimulating in 2021
4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Manufacturing Base Distribution, Product Type
4.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Recombinant Human Granulocyte Colony-Stimulating Product Type
4.3.3 Date of International Manufacturers Enter into Recombinant Human Granulocyte Colony-Stimulating Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Recombinant Human Granulocyte Colony-Stimulating Market Size by Company
4.5.1 Top Recombinant Human Granulocyte Colony-Stimulating Players in United States, Ranked by Revenue (2021)
4.5.2 United States Recombinant Human Granulocyte Colony-Stimulating Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Recombinant Human Granulocyte Colony-Stimulating Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Volume by Region (2017-2028)
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume by Region: 2017-2022
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Volume Forecast by Region (2023-2028)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Market Size in Value by Region (2017-2028)
5.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Region: 2017-2022
5.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Size YoY Growth 2017-2028
6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size YoY Growth 2017-2028
6.3.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size YoY Growth 2017-2028
6.4.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Corporation Information
7.1.2 Amgen Description and Business Overview
7.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.1.5 Amgen Recent Development
7.2 Qilu Pharmaceutical
7.2.1 Qilu Pharmaceutical Corporation Information
7.2.2 Qilu Pharmaceutical Description and Business Overview
7.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.2.5 Qilu Pharmaceutical Recent Development
7.3 Shijiazhuang Pharmaceutical
7.3.1 Shijiazhuang Pharmaceutical Corporation Information
7.3.2 Shijiazhuang Pharmaceutical Description and Business Overview
7.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.3.5 Shijiazhuang Pharmaceutical Recent Development
7.4 Kyowa Hakko Kirin
7.4.1 Kyowa Hakko Kirin Corporation Information
7.4.2 Kyowa Hakko Kirin Description and Business Overview
7.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.4.5 Kyowa Hakko Kirin Recent Development
7.5 Gensci
7.5.1 Gensci Corporation Information
7.5.2 Gensci Description and Business Overview
7.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.5.5 Gensci Recent Development
7.6 Amoytop Biotech
7.6.1 Amoytop Biotech Corporation Information
7.6.2 Amoytop Biotech Description and Business Overview
7.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.6.5 Amoytop Biotech Recent Development
7.7 Hangzhou Jiuyuan
7.7.1 Hangzhou Jiuyuan Corporation Information
7.7.2 Hangzhou Jiuyuan Description and Business Overview
7.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.7.5 Hangzhou Jiuyuan Recent Development
7.8 Huaxin
7.8.1 Huaxin Corporation Information
7.8.2 Huaxin Description and Business Overview
7.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.8.5 Huaxin Recent Development
7.9 Triprime
7.9.1 Triprime Corporation Information
7.9.2 Triprime Description and Business Overview
7.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.9.5 Triprime Recent Development
7.10 Sinovac
7.10.1 Sinovac Corporation Information
7.10.2 Sinovac Description and Business Overview
7.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.10.5 Sinovac Recent Development
7.11 Zhaoke
7.11.1 Zhaoke Corporation Information
7.11.2 Zhaoke Description and Business Overview
7.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Products Offered
7.11.5 Zhaoke Recent Development
7.12 Kawin
7.12.1 Kawin Corporation Information
7.12.2 Kawin Description and Business Overview
7.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Kawin Products Offered
7.12.5 Kawin Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Human Granulocyte Colony-Stimulating Industry Chain Analysis
8.2 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Recombinant Human Granulocyte Colony-Stimulating Distributors
8.3 Recombinant Human Granulocyte Colony-Stimulating Production Mode & Process
8.4 Recombinant Human Granulocyte Colony-Stimulating Sales and Marketing
8.4.1 Recombinant Human Granulocyte Colony-Stimulating Sales Channels
8.4.2 Recombinant Human Granulocyte Colony-Stimulating Distributors
8.5 Recombinant Human Granulocyte Colony-Stimulating Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer